KYTHERA Biopharmaceuticals reports positive results from Phase IIb study of ATX-101

KYTHERA Biopharmaceuticals, Inc. today presented positive results that found MRI measurements of patients treated with ATX-101 demonstrated a statistically significant reduction in submental fat , commonly known as double chin, during an oral session at The Aesthetic Meeting 2013, organized by the American Society for Aesthetic Plastic Surgery , ... (more)

http://www.news-medical.net/news/20130415/KYTHERA-Biopharmaceuticals-reports-positive-results-from-Phase-IIb-study-of-ATX-101.aspx